InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.432
+0.002 (0.08%)
Jul 11, 2025, 10:57 AM - Market open
InspireMD Market Cap
InspireMD has a market cap or net worth of $74.51 million as of July 11, 2025. Its market cap has increased by 18.64% in one year.
Market Cap
74.51M
Enterprise Value
50.68M
1-Year Change
18.64%
Ranking
Category
Stock Price
$2.43
Market Cap Chart
Since April 12, 2011, InspireMD's market cap has increased from $54.90M to $74.51M, an increase of 35.71%. That is a compound annual growth rate of 2.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 74.40M | 8.45% |
| Dec 31, 2024 | 68.60M | 13.20% |
| Dec 29, 2023 | 60.60M | 741.67% |
| Dec 30, 2022 | 7.20M | -70.49% |
| Dec 31, 2021 | 24.40M | 93.65% |
| Dec 31, 2020 | 12.60M | 223.08% |
| Dec 31, 2019 | 3.90M | -35.00% |
| Dec 31, 2018 | 6.00M | 500.00% |
| Dec 29, 2017 | 1.00M | -72.22% |
| Dec 30, 2016 | 3.60M | -47.83% |
| Dec 31, 2015 | 6.90M | -77.45% |
| Dec 31, 2014 | 30.60M | -62.08% |
| Dec 31, 2013 | 80.70M | 5.08% |
| Dec 31, 2012 | 76.80M | -32.93% |
| Dec 30, 2011 | 114.50M | 108.56% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 707.97B |
| Johnson & Johnson | 374.39B |
| AbbVie | 333.87B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 273.16B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 229.78B |
| AstraZeneca | 217.48B |